Dexmedetomidine transdermal patch - Teikoku Pharma USA

Drug Profile

Dexmedetomidine transdermal patch - Teikoku Pharma USA

Alternative Names: DMTS - Teikoku Pharma USA; TPU 006

Latest Information Update: 13 Jul 2017

Price : $50

At a glance

  • Originator Teikoku Pharma USA
  • Class Analgesics; Anxiolytics; Hypnosedatives; Imidazoles; Non-opioid analgesics; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Postoperative pain

Most Recent Events

  • 22 Jan 2017 Phase-II clinical trials in Postoperative pain in USA (Transdermal) (NCT02953054)
  • 12 Dec 2016 Chemical structure information added
  • 01 Nov 2016 Teikoku Pharma USA and Premier Research Group plan a phase II trial for Postoperative pain in Australia (Transdermal, patch) (NCT02953054)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top